Cytox Limited
Private Limited Company · Manchester
LiquidationUnited KingdomIncorporated 2004Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2021-12-31
IXBRL · 130 source facts · 25 selected values
Not assessedlegacy record
Accounts to 2021-12-31
IXBRL · 130 source facts · 25 selected values
Not assessed
legacy record
- Reporting period
- 2021-01-01 to 2021-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 79
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2021-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0110_05149130_20211231
- Source archive
- Accounts_Monthly_Data-September2022.zip
Accounts to 2020-12-31
IXBRL · 131 source facts · 25 selected values
Not assessedlegacy record
Accounts to 2020-12-31
IXBRL · 131 source facts · 25 selected values
Not assessed
legacy record
- Reporting period
- 2020-01-01 to 2020-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 82
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0094_05149130_20201231
- Source archive
- Accounts_Monthly_Data-September2021.zip
Accounts to 2019-12-31
IXBRL · 125 source facts · 21 selected values
Not assessedlegacy record
Accounts to 2019-12-31
IXBRL · 125 source facts · 21 selected values
Not assessed
legacy record
- Reporting period
- 2019-01-01 to 2019-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 74
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0085_05149130_20191231
- Source archive
- Accounts_Monthly_Data-December2020.zip
Accounts to 2018-12-31
IXBRL · 110 source facts · 17 selected values
Not assessedlegacy record
Accounts to 2018-12-31
IXBRL · 110 source facts · 17 selected values
Not assessed
legacy record
- Reporting period
- 2018-01-01 to 2018-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 64
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2014-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0070_05149130_20181231
- Source archive
- Accounts_Monthly_Data-September2019.zip
Accounts to 2017-12-31
IXBRL · 103 source facts · 13 selected values
Not assessedlegacy record
Accounts to 2017-12-31
IXBRL · 103 source facts · 13 selected values
Not assessed
legacy record
- Reporting period
- 2017-01-01 to 2017-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 55
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2014-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0058_05149130_20171231
- Source archive
- Accounts_Monthly_Data-September2018.zip
Accounts to 2015-12-31
IXBRL · 82 source facts · 22 selected values
Not assessedlegacy record
Accounts to 2015-12-31
IXBRL · 82 source facts · 22 selected values
Not assessed
legacy record
- Reporting period
- 2015-01-01 to 2015-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 58
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- uk-gaap-full-2009-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0036_05149130_20151231
- Source archive
- Accounts_Monthly_Data-November2016.zip
Registered details
05149130- Status
- Liquidation
- Type
- Private Limited Company
- Incorporated
- 2004-06-09
- Dissolved
- 2026-10-06
- Jurisdiction
- —
- Registered office
- 2ND FLOOR, ABBEY HOUSE, MANCHESTER, M2 4AB
Classification
1 SIC codes23112
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
2 SH01-derived rounds2023-02-17
£1,225,350 raised
£1,813,999 estimated post-money
2022-02-11
£2,352,660 raised
£7,275,391 estimated post-money
Research and innovation
4 matched grantsMICA: Dementias Platform UK 2 - Integrated Dementia Experimental MedicineActiveMRC · Research Grant · 2021-01-01 – 2027-06-29 · with 62 other participants£13,635,487whole project
MICA: Dementias Platform UK 2 - Integrated Dementia Experimental MedicineActive
MRC · Research Grant · 2021-01-01 – 2027-06-29 · with 62 other participants
£13,635,487
whole project
University Of OxfordleadAlectorAlzheimer'S Research UKAlzheimers SocietyApellis PharmaceuticalAstraZenecaAutifony Therapeutics LimitedBoostecBrainDTech SpACambridge Cognition LtdCardiff UniversityCatalan Health Institute (ICS)Cognetivity LtdCytOx LimitedDanish Research Centre for Magnetic Resonance (DRCMR)Eisai LtdEli Lilly & Company LtdEli Lilly (United Kingdom)EMBL European Bioinformatics Institute (EMBL - EBI)European Bank for induced pluripotent Stem CellsFerrer InternacionalF. Hoffmann-La Roche AGFlame UniversityGates Ventures, LLC.German Centre for Neurodegenerative DiseasesGlobal Alzheimer's Platform FoundationGskHarvard UniversityIMI Europe LimitedIrish Critical Care Clinical Trials NetworkIXICO Technologies LtdJanssen Research & Development LLCKing'S College LondonLudwig Maximilian University of Munich (LMU Munich)Mayo ClinicMcGill UniversityMedical Research Council (MRC)National Institute for Health and Care ResearchNational Institutes of Health (NIH)Roche PharmaceuticalsRodin Therapeutics, Inc.Rush University Medical CenterSouth Kazakhstan Medical AcademyStanford UniversityThe Hong Kong University of Science and TechnologyUCB PharmaUniversity College CopenhagenUniversity College LondonUniversity of BristolUniversity of California, IrvineUniversity of California, San FranciscoUniversity of CambridgeUniversity Of EdinburghUniversity of GlasgowUniversity of GothenburgUniversity of LeuvenUniversity of LiegeUniversity of LilleUniversity Of ManchesterUniversity Of NottinghamUniversity of San FranciscoUniversity of TorontoVU University Medical Center
Completion of software development and product launch activities associated with commercialisation of current Innovate UK Project (5195)Lead
Innovate UK · Feasibility Studies · 2020-06-01 – 2020-11-30
£215,491
awarded
The development and implementation of polygenic risk scoring algorithms for stratifying individuals for future cognitive decline due to Alzheimer's Disease in non-symptomatic and early cognitive impaired subjectsLeadInnovate UK · Collaborative R&D · 2018-03-01 – 2020-12-31 · with 1 other participant£573,966awarded
The development and implementation of polygenic risk scoring algorithms for stratifying individuals for future cognitive decline due to Alzheimer's Disease in non-symptomatic and early cognitive impaired subjectsLead
Innovate UK · Collaborative R&D · 2018-03-01 – 2020-12-31 · with 1 other participant
£573,966
awarded
Cytox Limitedlead£573,966
The utility of mTOR signalling pathway dysregulation and mutational profiling in the risk stratification for future cognitive decline in Mild Cognitive Impairment (MCI).LeadInnovate UK · Collaborative R&D · 2015-04-01 – 2018-03-31 · with 2 other participants£720,620awarded
The utility of mTOR signalling pathway dysregulation and mutational profiling in the risk stratification for future cognitive decline in Mild Cognitive Impairment (MCI).Lead
Innovate UK · Collaborative R&D · 2015-04-01 – 2018-03-31 · with 2 other participants
£720,620
awarded